EUDA Health Holdings Ltd (EUDA) Return on Sales (2022 - 2023)
EUDA Health Holdings (EUDA) posted quarterly Return on Sales of 0.46% for Q2 2023, down 45.0% year-over-year from 0.83% in Q2 2022, and down 3125.1% quarter-over-quarter from 0.01% in Q1 2023.
EUDA Health Holdings Ltd (EUDA) Return on Sales (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDA) has reported Return on Sales for 2 consecutive years, with 0.46% the latest figure, recorded in Q2 2023.
- In Q2 2023, Return on Sales fell 45.0% year-over-year to 0.46%; the TTM figure through Jun 2023 stood at 0.03% (changed N/A YoY), while the FY2025 annual figure was 0.0%, down 1.0% from the prior year.
- Return on Sales fell to 0.46% in Q2 2023 per EUDA's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q1 2022 and bottomed at 0.46% in Q2 2023.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -0.46% |
| Mar 31, 2023 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |